GlassScriptPhysician profile
Arman Hekmati
NPI 1326080128
$14,402.53
in general payments reported to CMS, 2019-2025
66 companies · $2,465 in 2025
The $2,465 reported for 2025 was more than what 95% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,447 · 2020: $1,566 · 2021: $2,445 · 2022: $2,265 · 2023: $2,094 · 2024: $2,121 · 2025: $2,465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,680.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,936.38 | 2019-2025 | Tezspire, Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $1,542.33 | 2019-2025 | Breztri, Farxiga, Fasenra |
| Lilly USA, LLC | $940.77 | 2019-2025 | Kisunla, Amyvid, Zepbound |
| Takeda Pharmaceuticals U.S.A., INC. | $718.01 | 2019-2025 | Trintellix |
| Abbvie INC. | $680.81 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $598.11 | 2022-2025 | |
| Axsome Therapeutics, INC. | $457.84 | 2022-2025 | Auvelity |
| Novartis Pharmaceuticals Corporation | $429.96 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $400.71 | 2019-2025 | Xifaxan, Relistor, Trulance |
| Pfizer INC. | $380.43 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $378.15 | 2019-2022 | |
| Bausch Health US, LLC | $354.17 | 2022-2025 | Wellbutrin, Aplenzin |
| Horizon Therapeutics Plc | $340.46 | 2021-2022 | |
| Astellas Pharma US INC | $327.58 | 2019-2021 | |
| Novo Nordisk INC | $316.64 | 2019-2025 | Ozempic, Rybelsus, Tresiba |
Show all 66 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $313.81 | 2021-2025 | |
| Edwards Lifesciences Corporation | $311.52 | 2020-2024 | Sapien 3 Ultra Resilia |
| Lundbeck LLC | $291.17 | 2023-2025 | Rexulti |
| Glaxosmithkline, LLC. | $280.12 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $257.56 | 2021-2025 | Synjardy, Jardiance, Tradjenta |
| Alnylam Pharmaceuticals INC. | $218.90 | 2022-2024 | Amvuttra, Onpattro |
| Regeneron Healthcare Solutions, INC. | $205.34 | 2021-2023 | Dupixent |
| Mylan Specialty L.P. | $178.57 | 2021-2024 | Yupelri |
| Biogen, INC. | $169.72 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $162.28 | 2021-2023 | |
| Abbott Laboratories | $157.32 | 2020-2024 | Freestyle Libre 3 |
| Genzyme Corporation | $155.54 | 2022-2025 | |
| Phathom Pharmaceuticals, INC. | $143.37 | 2024-2025 | Voquezna |
| Avanir Pharmaceuticals, INC. | $136.86 | 2019-2020 | |
| Allergan, INC. | $130.99 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $115.14 | 2023-2024 | Rexulti |
| Exact Sciences Corporation | $105.94 | 2023-2025 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $97.15 | 2023-2025 | Gemtesa |
| Radius Health, INC. | $86.69 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $84.86 | 2019-2022 | |
| Ironwood Pharmaceuticals, INC | $82.38 | 2023-2025 | Linzess |
| Sunovion Pharmaceuticals INC. | $73.22 | 2020-2022 | |
| Invivyd INC | $68.23 | 2025 | Pemgarda |
| Merck Sharp & Dohme LLC | $61.92 | 2020-2023 | Verquvo, Belsomra |
| Ardelyx, INC. | $46.61 | 2024 | Ibsrela |
| Ibsa Pharma INC. | $43.80 | 2025 | Licart, Flector, Tirosint |
| Aimmune Therapeutics, INC. | $42.11 | 2024-2025 | Zenpep |
| Nabriva Therapeutics, Plc | $41.59 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $38.82 | 2021 | |
| Corium, LLC | $38.17 | 2023 | Adlarity |
| Janssen Pharmaceuticals, INC | $38.05 | 2019 | |
| Almatica Pharma LLC | $32.93 | 2021-2022 | |
| Sanofi Pasteur INC. | $29.89 | 2019 | |
| Medicure Pharma INC. | $28.54 | 2021 | |
| Amarin Pharma, INC. | $22.67 | 2019 | |
| Optos, INC. | $22.35 | 2020 | |
| Mannkind Corporation | $22.22 | 2024 | |
| Esperion Therapeutics, INC. | $21.64 | 2021 | |
| Scilex Pharmaceuticals INC. | $21.64 | 2019 | |
| Heartflow, INC. | $20.68 | 2023 | Ffrct |
| Paratek Pharmaceuticals, INC. | $20.39 | 2024 | Nuzyra |
| Acorda Therapeutics, INC | $19.54 | 2019 | |
| Alvogen INC | $19.23 | 2023 | Teriparatide |
| Arbor Pharmaceuticals, INC. | $18.88 | 2020 | |
| Electromed, INC. | $18.67 | 2025 | Smartvest |
| Linus Health, INC. | $18.47 | 2022 | |
| Azurity Pharmaceuticals, INC. | $17.95 | 2023 | Horizant |
| Sun Pharmaceutical Industries INC. | $17.10 | 2021 | |
| Vertical Pharmaceuticals, LLC | $16.78 | 2019 | |
| Genentech USA, INC. | $16.77 | 2019 | |
| Dexcom, INC. | $16.09 | 2023 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arman Hekmati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.